Dr. Reddy’s Drops as U.S. Business Seen Facing More Pressure

  • First quarter results Tuesday saw net profit fall 80 percent
  • Company says big new products not likely until second half

Dr. Reddy’s Laboratories Ltd. plunged on concerns that competitive pressures in the U.S., which helped cut profit last quarter by nearly 80 percent, may linger for the balance of the year with few new drugs to win back the lost revenue.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.